CCL21 and breast carcinoma: Likewise, inhibition of MAPKp42/44 signaling with PD98059 had no effect on the migration of both control and CCL21 stimulated HS578T-Hyg breast cancer cells albeit cells displayed increased MAPKp42/44 levels upon CCL21 stimulation (Figure 2A).